See more : Alset Capital Acquisition Corp. (ACAXR) Income Statement Analysis – Financial Results
Complete financial analysis of SciBase Holding AB (publ) (SCIB.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SciBase Holding AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Modern Healthcare Technology Holdings Limited (0919.HK) Income Statement Analysis – Financial Results
- FireFly Metals Ltd (MNXMF) Income Statement Analysis – Financial Results
- Catcha Investment Corp (CHAAW) Income Statement Analysis – Financial Results
- Rennova Health, Inc. (RNVAW) Income Statement Analysis – Financial Results
- Mena Transport Public Company Limited (MENA.BK) Income Statement Analysis – Financial Results
SciBase Holding AB (publ) (SCIB.ST)
About SciBase Holding AB (publ)
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.25M | 17.89M | 11.73M | 9.52M | 9.28M | 6.90M | 6.86M | 6.44M | 4.15M | 1.60M | 97.00K | 0.00 |
| Cost of Revenue | 7.21M | 6.66M | 5.15M | 4.52M | 4.22M | 3.31M | 4.43M | 4.22M | 4.05M | 2.18M | 237.00K | 0.00 |
| Gross Profit | 16.04M | 11.24M | 6.58M | 5.00M | 5.06M | 3.59M | 2.43M | 2.22M | 103.00K | -577.00K | -140.00K | 0.00 |
| Gross Profit Ratio | 68.99% | 62.80% | 56.10% | 52.52% | 54.55% | 51.98% | 35.37% | 34.49% | 2.48% | -36.06% | -144.33% | 0.00% |
| Research & Development | 15.35M | 10.82M | 11.76M | 8.94M | 11.29M | 10.40M | 12.86M | 18.65M | 10.56M | 8.97M | 10.61M | 15.35M |
| General & Administrative | 12.02M | 11.18M | 9.81M | 9.67M | 8.26M | 8.85M | 9.10M | 8.50M | 10.98M | 12.16M | 10.25M | 9.08M |
| Selling & Marketing | 42.54M | 35.62M | 27.27M | 20.30M | 23.27M | 24.00M | 22.82M | 26.24M | 20.59M | 17.44M | 13.92M | 9.14M |
| SG&A | 54.56M | 46.81M | 37.07M | 29.97M | 31.53M | 32.85M | 31.92M | 34.73M | 31.57M | 29.60M | 24.17M | 18.22M |
| Other Expenses | 68.00K | 62.00K | 154.00K | 10.00K | 1.48M | -4.27M | -40.00K | -11.00K | -73.00K | -250.00K | 22.00K | 0.00 |
| Operating Expenses | 69.98M | 57.68M | 48.99M | 38.92M | 44.30M | 47.52M | 44.82M | 55.14M | 42.13M | 38.31M | 34.80M | 33.53M |
| Cost & Expenses | 77.18M | 64.34M | 54.14M | 43.44M | 48.52M | 50.83M | 49.25M | 59.36M | 46.17M | 40.49M | 35.03M | 33.53M |
| Interest Income | 1.19M | 194.00K | 174.00K | 202.00K | 311.00K | 0.00 | 0.00 | 3.00K | 19.00K | 61.00K | 29.00K | 7.43M |
| Interest Expense | 367.00K | 5.00K | 3.00K | 202.00K | 23.00K | 184.00K | 42.00K | 4.00K | 21.00K | 35.00K | 44.25M | 0.00 |
| Depreciation & Amortization | 3.39M | 3.65M | 3.02M | 2.62M | 2.85M | 841.00K | 613.00K | 332.00K | 170.00K | 322.00K | 520.00K | 581.34K |
| EBITDA | -51.83M | -39.33M | -38.58M | -32.19M | -36.44M | -43.18M | -41.70M | -52.75M | -41.36M | -38.54M | -34.40M | -32.95M |
| EBITDA Ratio | -222.97% | -220.89% | -331.83% | -340.20% | -396.69% | -626.03% | -607.96% | -820.09% | -997.64% | -2,430.69% | -36,017.53% | 0.00% |
| Operating Income | -53.94M | -46.45M | -42.41M | -33.92M | -39.24M | -44.02M | -42.43M | -53.09M | -41.98M | -38.89M | -34.94M | -33.53M |
| Operating Income Ratio | -232.05% | -259.64% | -361.64% | -356.23% | -423.03% | -638.05% | -618.65% | -824.95% | -1,011.23% | -2,430.69% | -36,017.53% | 0.00% |
| Total Other Income/Expenses | -1.65M | 3.25M | 632.00K | -239.00K | -189.00K | -196.00K | -31.00K | 9.00K | 444.00K | 26.00K | -44.22M | -7.43M |
| Income Before Tax | -55.59M | -43.17M | -41.78M | -35.01M | -39.59M | -44.22M | -42.46M | -53.09M | -41.53M | -38.87M | -79.15M | -40.96M |
| Income Before Tax Ratio | -239.13% | -241.33% | -356.25% | -367.70% | -426.84% | -640.89% | -619.10% | -824.81% | -1,000.53% | -2,429.06% | -81,601.03% | 0.00% |
| Income Tax Expense | 0.00 | -3.28M | -88.00K | -20.00K | -55.00K | -98.00K | -26.00K | 1.00K | 369.00K | -110.00K | 349.00K | 0.00 |
| Net Income | -55.59M | -39.90M | -41.69M | -34.99M | -39.54M | -44.22M | -42.46M | -53.09M | -41.53M | -38.76M | -79.50M | -40.96M |
| Net Income Ratio | -239.13% | -223.02% | -355.50% | -367.49% | -426.25% | -640.89% | -619.10% | -824.83% | -1,000.53% | -2,422.19% | -81,960.82% | 0.00% |
| EPS | -0.51 | -0.57 | -0.64 | -1.09 | -1.42 | -1.59 | -2.98 | -3.82 | -3.55 | -4.59 | -9.41 | -581.70 |
| EPS Diluted | -0.51 | -0.57 | -0.64 | -1.09 | -1.42 | -1.55 | -2.85 | -3.65 | -3.55 | -4.59 | -9.41 | -581.70 |
| Weighted Avg Shares Out | 107.98M | 70.55M | 64.64M | 32.23M | 27.84M | 27.84M | 14.23M | 13.88M | 11.71M | 8.45M | 8.45M | 70.42K |
| Weighted Avg Shares Out (Dil) | 107.98M | 70.55M | 64.64M | 32.23M | 27.84M | 28.50M | 14.88M | 14.54M | 11.71M | 8.45M | 8.45M | 70.42K |
Source: https://incomestatements.info
Category: Stock Reports